NCT06544707View on ClinicalTrials.gov

A Study Designed to Evaluate Tear Production

PHASE3CompletedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

October 15, 2024

Primary Completion Date

January 30, 2025

Study Completion Date

January 30, 2025

Conditions
Dry Eye Disease
Interventions
DRUG

0.003% AR-15512

Ophthalmic solution administered via topical ocular instillation

Trial Locations (1)

92663

Eye Research Foundation, Newport Beach

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY

NCT06544707 - A Study Designed to Evaluate Tear Production | Biotech Hunter | Biotech Hunter